Effects of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle

European Journal of Pharmacology

Volumn 364, Issue 1, 1999, Pages 43-48

  Pierno, Sabata ^a   De Luca, Annamaria ^a   Liantonio, Antonella ^a   Camerino, Claudia ^a   Conte Camerino, Diana ^a  

^a Unit of Pharmacology   (Italy)

Author keywords

Excitation contraction coupling; Pravastatin; Simvastatin; Skeletal muscle

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHYSIOLOGY; EXTENSOR DIGITORUM LONGUS MUSCLE; IN VITRO STUDY; MALE; MUSCLE CONTRACTILITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MUSCLE CONTRACTION; MUSCLE FIBERS; MUSCLE, SKELETAL; PRAVASTATIN; RATS; RATS, WISTAR; SIMVASTATIN;

EID: 0032902622     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00817-6     Document Type: Article

References (34)

1. Blum C.B. Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Am. J. Cardiol. 73:1994;3D-11D.
2. Brown B.G., Zhao X.-O., Sacco D.E., Albers J.J. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 87:1993;1781-1791.
3. Cannon S.C. Ion-channel defects and aberrant excitability in myotonia and periodic paralysis. Trends Neurosci. 19:1996;3-10.
4. Conte Camerino D., Tortorella V., Ferrannini E., Bryant S.H. The toxic effects of clofibrate and its metabolite on mammalian skeletal muscle: an electrophysiological study. Arch. Toxicol. 7:1984;482-484.
5. De Luca A., Conte Camerino D. Effects of aging on the mechanical threshold of rat skeletal muscle fibers. Pflügers Arch. 420:1992;407-409.
6. De Luca A., Tricarico D., Wagner R., Bryant S.H., Tortorella V., Conte Camerino D. Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions. J. Pharmacol. Exp. Ther. 260:1992;364-369.
7. - conductance of rat skeletal muscle. Eur. J. Pharmacol. 296:1996;215-222.
8. Dulhunty A. Internal citrate ions reduce the membrane potential for contraction threshold in mammalian skeletal muscle fibers. Biophys. J. 53:1988;609-615.
9. 2+ mobilization in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 27:1996;383-391.
10. George A.L. Jr. Molecular genetics of ion channel diseases. Kidney Int. 48:1995;1180-1190.
11. Goldstein J.L., Brown M.S. Regulation of mevalonate pathway. Nature (London). 343:1990;425-430.
12. Grundy S.M. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. New Engl. J. Med. 319:1988;24-33.
13. Hamelin B.A., Turgeon J. Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol. Sci. 19:1998;26-37.
14. Heiny J.A., Jong D., Bryant S.H., Conte Camerino D., Tortorella V. Enantiomeric effects on excitation-contraction coupling in frog skeletal muscle by a chiral phenoxy carboxylic acid. Biophys. J. 57:1990;147-152.
15. Kobashigawa J.A., Katznelson S., Laks H., Johnson J.A., Yeatman L., Wang X.M., Chia D., Terasaki P.L., Sabad A., Cogert G.A., Trosian K., Hamilton M.A., Moriguchi J.D., Kawata N., Hage A., Drinkwater D.C., Stevenson L.W. Effect of pravastatin on outcomes after cardiac transplantation. New Engl. J. Med. 333:1995;621-627.
16. Koga T., Shimada Y., Kuroda M., Tsujita Y., Hasegawa K., Yamazaki M. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim. Biophys. Acta. 1045:1990;115-120.
17. Komai T., Tsujita Y. Hepatocyte selectivity of HMG-CoA reductase inhibitors. Drug News and Perspectives. 7:1994;279-288.
18. Larsson L., Salviati G. Effect of age on calcium transport activity of sarcoplasmic reticulum in fast- and slow-twitch rat muscle fibers. J. Physiol. 419:1989;253-264.
19. Lehmann-Horn F., Rüdel R. Molecular pathophysiology of voltage-gated ion channels. Rev. Physiol. Biochem. Pharmacol. 128:1996;195-268.
20. Lijnen P., Petrov V. Cholesterol modulation of transmembrane cation transport system in human erythrocytes. Biochem. Mol. Med. 56:1995;52-62.
21. Lijnen P., Echevaria-Vazquez D., Petrov V. Influence of cholesterol-lowering on plasma membrane lipids and function. Meth. Find. Clin. Pharmacol. 18:1996;123-136.
22. 2+-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ. Res. 69:1991;1380-1388.
23. +-pump activity in erythrocytes of rabbits fed cholesterol. Int. J. Exp. Pathol. 76:1995;93-96.
24. Miledi R., Parker I., Zhu P.H. Calcium transients studied under voltage clamp control in frog twitch muscle fibers. J. Physiol. (London). 340:1983;649.
25. Morgan K.G., Bryant S.H. The mechanism of action of dantrolene sodium. J. Pharmacol. Exp. Ther. 201:1977;138-147.
26. 2+ increase and cell damage in L6 rat myoblast by HMG-Co A reductase inhibitor. Biochem. Biophys. Res. Commun. 202(3):1994;1579-1585.
27. 2+ responses in rat A10 vascular smooth muscle cells. Circ. Res. 74:1994;173-181.
28. Pierce L.R., Wysowsky D.K., Gross T.P. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA. 265:1990;71-75.
29. Pierno S., De Luca A., Tricarico D., Roselli A., Natuzzi F., Ferrannini E., Laico M., Conte Camerino D. Potential risk of myopathy by HMG-CoA recuctase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. J. Pharmacol. Exp. Ther. 275:1995;1490-1496.
30. Reijneveld J.C., Koot R.W., Bredman J.J., Joles J.A., Bar P.R. Differential effects of 3-hydroxy-3-methyl glutaryl-Coenzyme A reductase inhibitors on the development of myopathy in young rats. Pediatr. Res. 39:1996;1028-1035.
31. Rios E., Pizarro G. Voltage sensor of excitation-contraction coupling in skeletal muscle. Physiol. Rev. 71:1991;849.
32. Sirtori C. Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors. Pharmacol. Ther. 60:1993;431-459.
33. Smith P., Eydelloth R.S., Grossman S.J., Stubbs R.J., Schwartz M.S., Germershausen J.I., Vyas K.P., Kari P.H., MacDonald J.S. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies. J. Pharmacol. Exp. Ther. 257:1991;1225-1235.
34. Tallarida, R.J., Murray, R.B., 1987. Manual of Pharmacologic Calculations with Computer Programs. Springer-Verlag, New York, NY.